Patents Assigned to RTU PHARMACEUTICALS, LLC
  • Ready to use ketorolac formulations
    Patent number: 11116750
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: September 14, 2021
    Assignee: RTU Pharmaceuticals, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to use ketorolac formulations
    Patent number: 10278959
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: May 7, 2019
    Assignee: RTU Pharmaceuticals, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to use ketorolac formulations
    Patent number: 9962371
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: May 8, 2018
    Assignee: RTU PHARMACEUTICALS, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to use ketorolac formulations
    Patent number: 9421191
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: August 23, 2016
    Assignee: RTU PHARMACEUTICALS, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson
  • Ready to Use Ketorolac Formulations
    Publication number: 20120101142
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
    Type: Application
    Filed: October 21, 2011
    Publication date: April 26, 2012
    Applicant: RTU PHARMACEUTICALS, LLC
    Inventors: Joseph V. Pergolizzi, Alexander Mironov, Chad James Pickens, Douglas Giles Johnson